Displaying 1-10 of 10 result(s).
| Board Name | Posts By apmoore | Post Created |
|---|---|---|
| Stock Charts | The Dowcast has been correct on bot | 01/31/2017 8:35:21 PM |
| Keeping it Real | Putting Donald Trump into perspecti | 01/31/2017 8:29:38 PM |
| NUWE Nuwellis Inc. | the Dowcast has been accurate on bo | 01/31/2017 8:15:59 PM |
| Stock DD Board | TWTR predictions for the week of Ma | 03/06/2016 3:05:53 PM |
| Stock Info | TWTR was predicted accurately for 4 | 03/06/2016 3:00:38 PM |
| Stock Info | The Dowcast sets predictions for SU | 02/21/2016 2:56:57 PM |
| WINNERS CIRCLE | Following The Dowcast by investing | 01/24/2016 12:58:21 PM |
| SUNEQ SunEdison, Inc. | SUNE is forecasted every week http: | 01/05/2016 4:30:36 PM |
| Stock Info | DJIA The Dow Jones is expected to d | 12/08/2015 7:10:45 AM |
| AMBS Amarantus Bioscience Holdings | Many of the forecasts from The Dowc | 12/06/2015 12:32:50 PM |
Recent Articles
- Navigating the Monolithic Power Systems Class Action Lawsuit
- Deadline Approaches for Crocs Investors Amid Securities Action
- Musk and Altman Clash in High-Stakes OpenAI Legal Dispute
- Block, Inc. Securities Class Action: Essential Information for Investors
- Surging TON Token: Pavel Durov's Passport Return Sparks Growth
- Understanding the Class Action Lawsuit: Intellia Therapeutics Investors' Rights
- Consumer Tech Insights: Manus AI Hype and Tesla Innovations
- Pentagon's Review of Military Standards for Fitness and Grooming
- Netflix's Latest Film: High Costs and Low Returns Unveiled
- Charlie Munger's Insightful Strategies to Avoid Investment Mistakes
- Top Mid-Cap Stocks of the Week: D-Wave Quantum and IonQ Lead
- Investors of Alarum Technologies Ltd. Urged to Act Promptly
- Exploring Tesla's Challenges and Grab's Autonomous Vision
- Investors Alert: Class Action Lawsuit Filed Against MPWR
- Legal Actions Impacting Atkore Inc.: What You Need to Know
- FTAI Aviation Investors Urged to Join Class Action Funds
- Market Trends: Impact on Major Tech Stocks This Week
- Top Large-Cap Stock Performers: Notable Gains Last Week
- Investors Rally: Important Deadlines for IIPR Class Action
- Understanding AppLovin Corporation's Current Legal Circumstances
- Blockmedia's Strategic Move to Enhance AI Innovation in Louisiana
- Tensions Rise Amid US Airstrikes and Houthi Threats of Retaliation
- Tech Titans Shift Strategies Amid AI Developments and Challenges
- Important Update for Atkore Inc. Stakeholders: Act Now!
- Understanding Tariffs: How They Affect Small Businesses and You
- Legal Actions Unveiled: Atkore Inc. Faces Fraud Allegations
- Fluence Energy Faces Legal Challenges Amidst Fraud Allegations
- Trade Desk Faces Lawsuit for Alleged Securities Fraud Actions
- Investor Interest Grows in XPLR Infrastructure's Legal Dispute
- Market Shifts and Major Events in Cryptocurrency This Week
- Apple's Weekly Highlights: Court Hearings and Concert Innovation
- Market Dynamics: Gold Soars Amid Economic Concerns
- Weekly Political Insights: Tariffs, Trump, and Tesla's Future
- Investors Alert: Class Action Lawsuit Filed Against VG
- Sutro Biopharma's Promising Data in Ovarian Cancer Trials
- Insights Into Ibotta, Inc. and Its Recent Challenges for Investors
- Investor Alert: Class Action for Maravai LifeSciences Holdings
- Grimes Calls Out Elon Musk Over Children's Online Privacy Concerns
- Mary Trump Critiques Uncle's Policies: Economic Implications Loom
- Significant Victory Against ISIS Following Strategic Airstrike
- Examining the Future of Birthright Citizenship and Judicial Limits
- Charlamagne Tha God Questions Democratic Leadership Stability
- JPMorgan Faces Employee Lawsuit Over Prescription Prices
- Trade War Shifts Favor Towards Airbus Amid Boeing's Challenges
- ModivCare Inc. Securities Class Action: Participate Now
- Maximizing Passive Income through Ethereum Cloud Mining
- Mark Cuban’s Ambitious Plan to Innovate with Digital Experts
- Investor Concerns Rise as Musk Diverts Attention from Tesla
- Investors Urged to Act: Understanding Your Rights with EA
- Zentalis Pharmaceuticals Shares Promising Data on Ovarian Cancer Treatment